SCHEMBL6833726

SCHEMBL6833726

COc1ccc(CC(=O)Nc2cccc3cc(C(=O)Nc4ccc(C#N)cc4C(=O)O)[nH]c23)cc1OC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP14 Q460N5 1/20 0.45
POLB P06746 2/20 0.45
KDM4E B2RXH2 7/20 0.43
GAA P10253 4/20 0.42
CHEK1 O14757 1/20 0.41
PIM1 P11309 1/20 0.41
MAPK8 P45983 1/20 0.41
CLK4 Q9HAZ1 1/20 0.41
HSD17B10 Q99714 5/20 0.41
LMNA P02545 4/20 0.41
ALDH1A1 P00352 3/20 0.41
GFER P55789 1/20 0.41
MAPT P10636 3/20 0.41
HTT P42858 3/20 0.41
HPGD P15428 3/20 0.41
TSHR P16473 2/20 0.41
MAPK1 P28482 2/20 0.41
USP2 O75604 1/20 0.41
ALOX15 P16050 1/20 0.41
NPSR1 Q6W5P4 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6834350 0.90 ALDH1A1 (0.50) PARP14POLBKDM4EALDH1A1MAPT
SCHEMBL6833069 0.90 POLB (0.48) PARP14POLBKDM4EGAAMAPK8
SCHEMBL6834412 0.89 KDM4E (0.55) KDM4EGAAHSD17B10LMNAALDH1A1
SCHEMBL6834298 0.88 MEN1 (0.44) PARP14KDM4EMAPK8LMNAALDH1A1
SCHEMBL6834072 0.88 ALDH1A1 (0.41) PARP14KDM4ELMNAALDH1A1MAPT
SCHEMBL6834504 0.87 LMNA (0.47) PARP14KDM4ELMNAALDH1A1KMT2A
SCHEMBL6833157 0.87 PARP14 (0.42) PARP14POLBKDM4EMAPK8LMNA
SCHEMBL6833113 0.86 SMN1; SMN2 (0.46) POLBKDM4ELMNAALDH1A1MAPT
SCHEMBL6833683 0.86 NR1H4 (0.48) ALDH1A1
SCHEMBL6818890 0.86 TRPV1 (0.46) PARP14KDM4EGAALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040110802-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-06-10 US claimed
US-20040110802-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-06-10 US disclosed
WO-2004018428-A1 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110802-A1 Antibacterial benzoic acid derivatives GABRD, GABBR1, GABRA1 PARP14 2395/4885POLB 637/4885KDM4E 1240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.